Neurology News with information about conditions, treatments, current studies and breakthroughs.
TMS for Schizophrenia
Schizophrenia is a complex and challenging mental health disorder that affects millions of individuals worldwide. Characterized by a range of [...]
Nerve Conduction Study
Welcome to Countryside Neurology! We want to ensure that your experience with us is as comfortable and informative as possible. [...]
Cranial Nerve Exam
A cranial nerve examination is a systematic assessment of the twelve pairs of cranial nerves that originate from the brain [...]
Conditions Requiring EMG and EEG Exams
EEG (electroencephalogram) and EMG (electromyography) exams are used to diagnose and evaluate a wide range of neurological and neuromuscular conditions. [...]
EEG vs EMG Exams
Deciding whether to get an EEG (electroencephalogram) or an EMG (electromyography) exam depends on your symptoms, medical history, and the [...]
Neuropathy
Neuropathy, also known as peripheral neuropathy, is a term that refers to a group of conditions that involve damage or [...]
- UF Neurology Faculty and Trainees Present at 2026 AAN Annual Meeting May 13, 2026Educating the Next Generation UF faculty led or contributed to more than 10 invited courses and seminars at the meeting, covering topics from Parkinson’s disease management and movement disorder surgery to neuroethics, epilepsy, autoimmune neurology, and neuromuscular junction disorders. Faculty who led sessions included Ashley Rawls, Gregory Pontone, Leonardo Brito de Almeida, S. Subramony, Matt…
- UF research helps establish new FDA pathway for Parkinson’s diagnostics May 11, 2026On Friday, April 3, the U.S. Food and Drug Administration, or FDA, granted De Novo classification to Neuropacs™ Corp. for its diffusion MRI-based software, neuropacs™, which is designed to assist neurologists and neuroradiologists evaluate individuals with early-stage Parkinson’s disease. The approval was made possible by a National Institutes of Health-funded study led by University of Florida researchers.…
- May is CurePSP Month of Awareness May 8, 2026May is widely recognized as Progressive Supranuclear Palsy (PSP) Awareness Month, dedicated to raising awareness for the rare neurodegenerative disease that affects movement, vision, and cognition. It is also an opportunity to recognize the individuals living with PSP, as well as the families and caregivers who support them. Learn more about our PSP Center of Excellence.…
- New Study Reveals Environmental Factors May Speed ALS Progression May 6, 2026At the Norman Fixel Institute for Neurological Diseases, research fellow A. Enrique Martinez-Nunez, M.D., Movement Disorders neurologist and ALS research fellow, is working to answer one of the most urgent questions in neurodegenerative disease: why does ALS progress differently from one patient to another? As the institute’s ALS research fellow, made possible through a philanthropic gift…
Get Social